280 related articles for article (PubMed ID: 24534595)
1. Eosinophilic pneumonia induced by ceftaroline.
Griffiths CL; Gutierrez KC; Pitt RD; Lovell RD
Am J Health Syst Pharm; 2014 Mar; 71(5):403-6. PubMed ID: 24534595
[TBL] [Abstract][Full Text] [Related]
2. Ceftaroline-induced eosinophilic pneumonia.
Desai KR; Burdette SD; Polenakovik HM; Hagaman J; Pleiman CM
Pharmacotherapy; 2013 Jul; 33(7):e166-9. PubMed ID: 23649990
[TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy.
Bucheit J; Collins R; Joshi P
Am J Health Syst Pharm; 2014 Jan; 71(2):110-3. PubMed ID: 24375602
[TBL] [Abstract][Full Text] [Related]
4. Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions.
Jones JM; Richter LM; Alonto A; Leedahl DD
Am J Health Syst Pharm; 2015 Feb; 72(3):198-202. PubMed ID: 25596602
[TBL] [Abstract][Full Text] [Related]
5. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin-associated eosinophilic pneumonia with rechallenge: a case report
.
Nickerson M; Bhargava A; Kale-Pradhan PB
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):521-524. PubMed ID: 28406091
[TBL] [Abstract][Full Text] [Related]
7. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
[TBL] [Abstract][Full Text] [Related]
8.
Gaikwad V; Gohel T; Panickar S; Chincholkar V; Mangalkar S
Indian J Pathol Microbiol; 2016; 59(4):496-498. PubMed ID: 27721280
[TBL] [Abstract][Full Text] [Related]
9. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience.
Lipsky BA; Cannon CM; Ramani A; Jandourek A; Calmaggi A; Friedland HD; Goldstein EJ
Diabetes Metab Res Rev; 2015 May; 31(4):395-401. PubMed ID: 25417910
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
11. Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Burnett YJ; Echevarria K; Traugott KA
Ann Pharmacother; 2016 Dec; 50(12):1051-1059. PubMed ID: 27520326
[TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.
Pasquale TR; Tan MJ; Trienski TL; File TM
J Chemother; 2015 Feb; 27(1):29-34. PubMed ID: 24621164
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
[TBL] [Abstract][Full Text] [Related]
15. A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline.
Yam FK; Kwan BK
Am J Health Syst Pharm; 2014 Sep; 71(17):1457-61. PubMed ID: 25147169
[TBL] [Abstract][Full Text] [Related]
16. DISC: Describing Infections of the Spine treated with Ceftaroline.
Watkins RR; Yendewa G; Burdette SD; Horattas S; Haller NA; Mangira C; Salata RA; Bonomo RA
J Glob Antimicrob Resist; 2018 Jun; 13():146-151. PubMed ID: 29337085
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic Pneumonia Putatively Induced by Vancomycin: A Case Report.
Isono T; Sawaguchi H; Kusumoto H; Shiono H
Am J Case Rep; 2019 Sep; 20():1440-1445. PubMed ID: 31564716
[TBL] [Abstract][Full Text] [Related]
18. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Poon H; Chang MH; Fung HB
Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking-induced acute eosinophilic pneumonia: A case report.
Liu X; Sun W; Meng W; Xiao Y; Feng G; Shi B
Medicine (Baltimore); 2019 Mar; 98(9):e14704. PubMed ID: 30817609
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
